Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Human Cdc45 is a proliferation-associated antigen.

Pollok S, Bauerschmidt C, Sänger J, Nasheuer HP, Grosse F.

FEBS J. 2007 Jul;274(14):3669-84. Epub 2007 Jul 3.

2.

HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues.

Todorov IT, Werness BA, Wang HQ, Buddharaju LN, Todorova PD, Slocum HK, Brooks JS, Huberman JA.

Lab Invest. 1998 Jan;78(1):73-8.

PMID:
9461123
3.

Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.

Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, Kim TE, Kim JW.

Clin Cancer Res. 2004 Dec 15;10(24):8386-95.

4.

The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells.

Endl E, Kausch I, Baack M, Knippers R, Gerdes J, Scholzen T.

J Pathol. 2001 Nov;195(4):457-62.

PMID:
11745678
5.

DNA replication licensing and human cell proliferation.

Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L, Williams ED, Williams GH.

J Cell Sci. 2001 Jun;114(Pt 11):2027-41.

6.

Immunohistochemical evaluation of minichromosome maintenance protein 7 in astrocytoma grading.

Facoetti A, Ranza E, Grecchi I, Benericetti E, Ceroni M, Morbini P, Nano R.

Anticancer Res. 2006 Sep-Oct;26(5A):3513-6.

7.
8.

Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China.

Huang B, Hu B, Su M, Tian D, Guo Y, Lian S, Liu Z, Wu X, Li Q, Zheng R, Gao Y.

Hum Pathol. 2011 Jun;42(6):808-16. doi: 10.1016/j.humpath.2010.04.022. Epub 2011 Jan 15.

PMID:
21237484
9.

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.

Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS, Tan D.

BMC Cancer. 2006 Aug 1;6:203.

10.

Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.

Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK, Kim S, Kang CS, Lee KY, Hong OK, Lee SH, Kwon HS, Cha BY, Kim JW.

Exp Mol Pathol. 2010 Feb;88(1):138-42. doi: 10.1016/j.yexmp.2009.09.015. Epub 2009 Oct 8.

PMID:
19818763
11.

Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.

Guzińska-Ustymowicz K, Pryczynicz A, Kemona A, Czyzewska J.

Anticancer Res. 2009 Aug;29(8):3049-52.

12.

MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.

Giaginis C, Giagini A, Tsourouflis G, Gatzidou E, Agapitos E, Kouraklis G, Theocharis S.

Dig Dis Sci. 2011 Mar;56(3):777-85. doi: 10.1007/s10620-010-1348-5. Epub 2010 Aug 6.

PMID:
20694513
14.

Protein interaction and cellular localization of human CDC45.

Takaya J, Kusunoki S, Ishimi Y.

J Biochem. 2013 Apr;153(4):381-8. doi: 10.1093/jb/mvt004. Epub 2013 Jan 30.

PMID:
23364835
15.

Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?

Kimura F, Kawamura J, Watanabe J, Kamoshida S, Kawai K, Okayasu I, Kuwao S.

Diagn Cytopathol. 2010 Mar;38(3):161-7. doi: 10.1002/dc.21190.

PMID:
19821496
16.

Central role for cdc45 in establishing an initiation complex of DNA replication in Xenopus egg extracts.

Mimura S, Masuda T, Matsui T, Takisawa H.

Genes Cells. 2000 Jun;5(6):439-52.

17.

Cdc45 degradation during differentiation and apoptosis.

Pollok S, Grosse F.

Biochem Biophys Res Commun. 2007 Nov 3;362(4):910-5. Epub 2007 Aug 22.

PMID:
17767920
18.

Characterization of the interaction between the human DNA topoisomerase IIbeta-binding protein 1 (TopBP1) and the cell division cycle 45 (Cdc45) protein.

Schmidt U, Wollmann Y, Franke C, Grosse F, Saluz HP, Hänel F.

Biochem J. 2008 Jan 1;409(1):169-77.

PMID:
17887956
19.

Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.

Giaginis C, Georgiadou M, Dimakopoulou K, Tsourouflis G, Gatzidou E, Kouraklis G, Theocharis S.

Dig Dis Sci. 2009 Feb;54(2):282-91. doi: 10.1007/s10620-008-0305-z. Epub 2008 May 9.

PMID:
18465232
20.

Inhibition of centrosome protein assembly leads to p53-dependent exit from the cell cycle.

Srsen V, Gnadt N, Dammermann A, Merdes A.

J Cell Biol. 2006 Aug 28;174(5):625-30.

Supplemental Content

Support Center